Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1561

1.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1977-83.

PMID:
15184600
2.

E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.

Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ.

Neurology. 2000 Jan 25;54(2):403-6.

PMID:
10668702
3.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
4.

APOE, vascular pathology, and the AD brain.

Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA.

Neurology. 2005 Jul 26;65(2):259-65.

PMID:
16043796
5.

The importance of neuritic plaques and tangles to the development and evolution of AD.

Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1984-9.

PMID:
15184601
6.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

7.

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Tsuboi Y, Josephs KA, Cookson N, Dickson DW.

Neurology. 2003 Jan 28;60(2):240-5.

PMID:
12552038
8.

[Expression of apolipoprotein E in Alzheimer's disease and its significance].

He SR, Liu DG, Wang S, Xia YJ.

Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):556-60. Chinese.

PMID:
16468304
9.

The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.

Hirono N, Hashimoto M, Yasuda M, Ishii K, Sakamoto S, Kazui H, Mori E.

Neurology. 2002 Mar 12;58(5):743-50.

PMID:
11889238
10.

Alzheimer disease without neocortical neurofibrillary tangles: "a second look".

Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Apr 13;62(7):1141-7.

PMID:
15079014
11.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
12.
13.

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A.

Neurology. 2009 Apr 28;72(17):1487-94. doi: 10.1212/WNL.0b013e3181a2e8d0. Epub 2009 Apr 1.

PMID:
19339712
14.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

15.

Cholinergic dysfunction in diseases with Lewy bodies.

Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J.

Neurology. 2000 Jan 25;54(2):407-11.

PMID:
10668703
16.

Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese.

Sodeyama N, Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E, Mizusawa H.

Neurology. 2000 Jan 25;54(2):443-6.

PMID:
10668711
17.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
18.

A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.

Licastro F, Veglia F, Chiappelli M, Grimaldi LM, Masliah E.

Neurobiol Aging. 2004 Sep;25(8):1017-22.

PMID:
15212826
19.

Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.

Ohm TG, Scharnagl H, März W, Bohl J.

Acta Neuropathol. 1999 Sep;98(3):273-80.

PMID:
10483785
20.

Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.

Drigalenko E, Poduslo S, Elston R.

Neurology. 1998 Jul;51(1):131-5.

PMID:
9674791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk